Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $438.25 | 10 | 77.8% |
| Unspecified | $125.00 | 1 | 22.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $334.25 | 6 | $0 (2022) |
| Indivior Inc. | $125.00 | 1 | $0 (2019) |
| Braeburn Inc. | $104.00 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47.74 | 2 | Braeburn Inc. ($47.74) |
| 2023 | $56.26 | 2 | Braeburn Inc. ($56.26) |
| 2022 | $23.13 | 1 | Alkermes, Inc. ($23.13) |
| 2020 | $125.00 | 1 | Alkermes, Inc. ($125.00) |
| 2019 | $146.06 | 2 | Indivior Inc. ($125.00) |
| 2018 | $123.14 | 1 | Alkermes, Inc. ($123.14) |
| 2017 | $41.92 | 2 | Alkermes, Inc. ($41.92) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: Opioid Use Disorder | ||||||
| 02/07/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Opioid Use Disorder | ||||||
| 12/07/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Opioid Use Disorder | ||||||
| 11/17/2023 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Opioid Use Disorder | ||||||
| 10/19/2022 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CNS | ||||||
| 02/06/2020 | Alkermes, Inc. | Vivitrol (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CNS | ||||||
| 07/18/2019 | Indivior Inc. | SUBOXONE (Drug) | — | Cash or cash equivalent | $125.00 | Research |
| Study: Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information • Category: OUD | ||||||
| 06/05/2019 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: CNS | ||||||
| 04/19/2018 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $123.14 | General |
| Category: CNS | ||||||
| 10/25/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: CNS | ||||||
| 04/27/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Quantitative Testing of Prescriber Knowledge, Attitudes and Behavior about SUBOXONE buprenorphine and naloxone Sublingual Film CIII Safety and Use Information | Indivior Inc. | $125.00 | 1 |
About Dr. Joel Nathan, MD
Dr. Joel Nathan, MD is a Addiction Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487749552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joel Nathan, MD has received a total of $563.25 in payments from pharmaceutical and medical device companies, with $47.74 received in 2024. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($438.25).
Practice Information
- Specialty Addiction Medicine
- Location New York, NY
- Active Since 10/04/2006
- Last Updated 03/13/2015
- Taxonomy Code 207RA0401X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487749552
Products in Payments
- Vivitrol 380 mg (Drug) $165.06
- SUBOXONE (Drug) $125.00
- Vivitrol (Drug) $125.00
- BRIXADI (Drug) $104.00
- VIVITROL (Drug) $44.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction Medicine Doctors in New York
Dr. Daniel Karlin, M.d., M.a, M.D., M.A
Addiction Medicine — Payments: $100,531
Dr. John Mariani, M.d, M.D
Addiction Medicine — Payments: $38,062
Dr. Stuart Gitlow, Md, Mph, Mba, MD, MPH, MBA
Addiction Medicine — Payments: $28,850
Dr. Ramon Ravelo, M.d, M.D
Addiction Medicine — Payments: $11,426
Dr. James Wolberg, Md, MD
Addiction Medicine — Payments: $3,928
Dr. Jayant Gandhi, Md, MD
Addiction Medicine — Payments: $3,197